The U.S. International Trade Commission has begunan investigation into allegations that a Chinese company is importing genetically-engineered rice seeds for medical uses that copy patented technology owned by Kansas developer
- Ventria said it developed rice seeds to produce a protein called
albumin used in the manufacture of medicines like immunotherapy drugs, gene therapies and vaccines, including ones for Covid-19 Wuhan Healthgen , a company founded by a former Ventria scientist, is making a plant-based albumin using techniques patented by Ventria, according to the complaint- Ventria said it had filed a civil trade secret suit against the former ...
- Ventria said it had filed a civil trade secret suit against the former ...
Learn more about Bloomberg Law or Log In to keep reading:
Learn About Bloomberg Law
AI-powered legal analytics, workflow tools and premium legal & business news.
Already a subscriber?
Log in to keep reading or access research tools.